findmyKOL

Heidi Jacobe, MD

Basic profile

The University of Texas Southwestern Medical Center

ORCIDNPI
RegionDallas, TX · South CentralSpecialtyDermatologyFocusDermatology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding2008–2021Why? →

Heidi Jacobe is a Dermatology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 176 publications with 4,258 citations (h-index 35); ClinicalTrials.gov lists 3 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
176publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,258citations

Total citations across indexed works.

35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
2NIH grants · 2008–2021

Federally funded research awards.

View funding

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    31.7%
    Porphyrin Precursor17.8%
    Aminolevulinic acid hcl100%
    Part B, office-administered22 patients
    Folate Analog Metabolic Inhibitor13.9%
    Methotrexate100%
    Part D<11 patients
  • Nervous system

    27.4%
    Gabapentinoids22.6%
    Gabapentin100%
    Part D13 patients
    Opioid Agonist4.8%
    Tramadol Hcl Er100%
    Part D<11 patients
  • Dermatology

    17.4%
    Corticosteroid17.4%
    Triamcinolone Acetonide100%
    Part D23 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20082021 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”